Breaking News Instant updates and real-time market news.

2020-12-03 17:26:59 CLI Mack-Cali Realty $13.99 / +0.29 (+2.12%) 17:26 12/03/20 12/03 17:26 12/03/20 17:26	Mack-Cali Realty announces $61M sale of NJ property Mack-Cali announced the disposition of 581 Main Street, a 203,335-square-foot office building in Woodbridge Township, NJ.
CLI Mack-Cali Realty $13.99 / +0.29 (+2.12%) 08/04/20 Fly Intel: Top five analyst downgrades 08/04/20 Deutsche Bank Mack-Cali Realty downgraded to Hold from Buy at Deutsche Bank 07/20/20 Deutsche Bank Mack-Cali Realty price target lowered to $20 from $22 at Deutsche Bank 03/25/20 Evercore ISI Mack-Cali Realty downgraded to In Line from Outperform at Evercore ISI

2020-12-03 17:26:59

CLI

Mack-Cali Realty

$13.99 / +0.29 (+2.12%)

17:26

12/03/20

12/03

17:26

12/03/20

17:26

Mack-Cali Realty announces $61M sale of NJ property

Mack-Cali announced the disposition of 581 Main Street, a 203,335-square-foot office building in Woodbridge Township, NJ.

CLI Mack-Cali Realty

$13.99 / +0.29 (+2.12%)

08/04/20: Fly Intel: Top five analyst downgrades

08/04/20 Deutsche Bank: Mack-Cali Realty downgraded to Hold from Buy at Deutsche Bank

07/20/20 Deutsche Bank: Mack-Cali Realty price target lowered to $20 from $22 at Deutsche Bank

03/25/20 Evercore ISI: Mack-Cali Realty downgraded to In Line from Outperform at Evercore ISI

TODAY'S FREE FLY STORIES

Recommendations	FireEye price target raised to $19 from $17 at Barclays » 07:00 01/21/21 01/21 07:00 01/21/21 07:00 FEYE FireEye $22.39 / +0.2 (+0.90%) Barclays analyst Saket… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FEYE FireEye $22.39 / +0.2 (+0.90%) 12/28/20 FireEye director sells 50K shares of common stock 12/11/20 FireEye adds Blackstone senior managing director to board as deal closes 12/08/20 FireEye falls 8% to $14.26 per share after disclosing cyber attack in 8-K filing 12/08/20 FireEye discloses attack by 'sophisticated cyber threat actor' FEYE FireEye $22.39 / +0.2 (+0.90%) 01/12/21 Mizuho FireEye price target raised to $21 from $17 at Mizuho 01/08/21 Morgan Stanley FireEye price target raised to $19 from $14 at Morgan Stanley 01/08/21 Goldman Sachs FireEye price target raised to $25 from $17 at Goldman Sachs 01/05/21 Piper Sandler FireEye price target raised to $22 from $16 at Piper Sandler FEYE FireEye $22.39 / +0.2 (+0.90%) 10/27/20 FireEye sees FY20 EPS 28c-30c, consensus 25c 10/27/20 FireEye sees Q4 EPS 9c-11c, consensus 10c 10/27/20 FireEye reports Q EPS 11c, consensus 7c 10/27/20 Notable companies reporting after market close FEYE FireEye $22.39 / +0.2 (+0.90%) 01/19/21 FireEye releases tool for auditing networks after SolarWinds hack, ZDNet says 01/11/21 FBI investigating Russian-linked postcard sent to FireEye CEO, Reuters reports 12/24/20 Suspected Russian hack on agencies failed to breach CrowdStrike, Reuters reports 12/17/20 Nuclear weapons agency breached amid massive espionage operation, Politico says FEYE FireEye $22.39 / +0.2 (+0.90%) 12/23/20 Telos, Palo Alto seen among potential beneficiaries of Sunburst hack 12/08/20 Fly Intel: After-Hours Movers 11/20/20 Fly Intel: Wall Street's top stories for Friday 11/20/20 Fly Intel: Wall Street's top stories at midday 02/11/21 Technology & Internet Virtual Conference 02/02/21 FireEye - FEYE FEYE FireEye $22.39 / +0.2 (+0.90%) 12/28/20 FireEye call volume above normal and directionally bullish 12/24/20 Unusually active option classes on open December 24th 12/18/20 FireEye call volume above normal and directionally bullish 12/18/20 Unusually active option classes on open December 18th
Recommendations	Citizens Financial price target raised to $49 from $44 at Barclays » 07:00 01/21/21 01/21 07:00 01/21/21 07:00 CFG Citizens Financial $40.08 / -0.75 (-1.84%) Barclays analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events CFG Citizens Financial $40.08 / -0.75 (-1.84%) 01/20/21 Citizens Financial sees high single digit decrease in FY21 NIM 01/20/21 Citizens Financial board approves $750M common stock repurchase program 01/20/21 Citizens Financial: 'Well positioned to benefit from economic recovery in 2021' 01/20/21 Citizens Financial reports CET1 capital ratio 10.0% at December 31, 2020 CFG Citizens Financial $40.08 / -0.75 (-1.84%) 06:29 Today RBC Capital Citizens Financial price target raised to $45 from $29 at RBC Capital 01/12/21 UBS UBS downgrades Citizens on revenue headwinds, Wells new top pick 01/11/21 UBS Citizens Financial downgraded to Neutral from Buy at UBS 01/06/21 Deutsche Bank Citizens Financial price target raised to $41 from $31 at Deutsche Bank CFG Citizens Financial $40.08 / -0.75 (-1.84%) 01/20/21 Citizens Financial reports Q4 underlying EPS $1.04, consensus 91c 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 10/16/20 Citizens Financial reports Q3 underlying EPS 73c, consensus 74c CFG Citizens Financial $40.08 / -0.75 (-1.84%) 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says 08/15/20 PNC, KeyCorp among large regional banks offering steady dividends, Barron's says CFG Citizens Financial $40.08 / -0.75 (-1.84%) 10/16/20 Fly Intel: Pre-market Movers 02/24/21 22nd Annual Virtual Financial Services Forum 04/16/21 Citizens Financial - CFG
Recommendations	BorgWarner price target raised to $41 from $39 at Barclays » 06:59 01/21/21 01/21 06:59 01/21/21 06:59 BWA BorgWarner $40.88 / +1.59 (+4.05%) Barclays analyst Brian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BWA BorgWarner $40.88 / +1.59 (+4.05%) 10/22/20 BorgWarner collaborating with Michigan university on connected vehicle project 10/07/20 Simpson Manufacturing to replace Delphi Technologies in S&P 400 at open on 10/7 10/02/20 BorgWarner-backed Romeo said in talks to come public via SPAC deal 10/01/20 Simpson Manufacturing to replace Delphi Technologies in S&P 400 at open on 10/7 BWA BorgWarner $40.88 / +1.59 (+4.05%) 01/20/21 Deutsche Bank BorgWarner named 'Catalyst Call: Buy Idea' at Deutsche Bank 11/12/20 Wolfe Research BorgWarner downgraded to Peer Perform from Outperform at Wolfe Research 11/09/20 Fly Intel: Top five analyst downgrades 11/09/20 Morgan Stanley BorgWarner downgraded to Underweight from Equal Weight at Morgan Stanley BWA BorgWarner $40.88 / +1.59 (+4.05%) 10/29/20 BorgWarner raises FY20 revenue view to $9.7B-$9.85B from $8B-$8.4B 10/29/20 BorgWarner sees Q4 revenue $3.46B-$3.61B, consensus $3.05B 10/29/20 BorgWarner reports Q3 adj. EPS 88c, consensus 77c 10/28/20 Notable companies reporting before tomorrow's open BWA BorgWarner $40.88 / +1.59 (+4.05%) 10/02/20 RMG in discussions to make Romeo Systems public through merger, Bloomberg says BWA BorgWarner $40.88 / +1.59 (+4.05%) 11/04/20 Amazon, AMD upgrades among today's top calls on Wall Street 02/11/21 BorgWarner - BWA BWA BorgWarner $40.88 / +1.59 (+4.05%) 11/19/20 Unusual call flow in option market yesterday
Hot Stocks	Boston Scientific to acquire Preventice Solutions for $925M in cash upfront » 06:59 01/21/21 01/21 06:59 01/21/21 06:59 BSX Boston Scientific $36.65 / +0.38 (+1.05%) Boston Scientific… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BSX Boston Scientific $36.65 / +0.38 (+1.05%) 01/11/21 Boston Scientific announces Lotus Edge recall, sees $225M-$300M of charges 12/14/20 Boston Scientific says stipulation of dismissal filed in Nevro patent case 12/14/20 Nevro to conclude its Boston Scientific lawsuit in DC area 12/01/20 Boston Scientific to sell BTG Specialty Pharmaceuticals business for $800M BSX Boston Scientific $36.65 / +0.38 (+1.05%) 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler 01/12/21 Piper Sandler Piper says Boston Scientific pullback an opportunity to build positions 12/23/20 Piper Sandler Boston Scientific a name to own at current share levels, says Piper Sandler 12/15/20 Goldman Sachs Boston Scientific downgraded to Buy from Conviction Buy at Goldman Sachs BSX Boston Scientific $36.65 / +0.38 (+1.05%) 01/12/21 Boston Scientific sees FY20 revenue $9.91B, consensus $10.08B 01/12/21 Boston Scientific reports preliminary Q4 revenue $2.71B, consensus $2.86B 10/28/20 Boston Scientific reports Q3 adj. EPS 37c, consensus 25c 10/27/20 Notable companies reporting before tomorrow's open 22 May BSX Boston Scientific $36.65 / +0.38 (+1.05%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: Pre-market Movers 10/28/20 Fly Intel: Pre-market Movers 02/03/21 Boston Scientific - BSX BSX Boston Scientific $36.65 / +0.38 (+1.05%) 10/14/20 Boston Scientific put volume heavy and directionally bearish 10/07/20 Boston Scientific put volume heavy and directionally bearish 08/31/20 Boston Scientific put volume heavy and directionally bearish 08/21/20 Boston Scientific call volume above normal and directionally bullish
Recommendations	Morgan Stanley price target raised to $78 from $55 at RBC Capital » 06:59 01/21/21 01/21 06:59 01/21/21 06:59 MS Morgan Stanley $74.83 / -0.16 (-0.21%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/20/21 Morgan Stanley expects net new assets to remain above historical levels 01/20/21 Morgan Stanley doesn't see any change to policy rates in the near-term 01/20/21 Morgan Stanley: LT goal is for wealth management to generate margin of over 30% 01/20/21 Morgan Stanley CEO: 2021 to be a transition year MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/20/21 BMO Capital Morgan Stanley price target raised to $81 from $78 at BMO Capital 01/11/21 Piper Sandler Morgan Stanley price target raised to $76 from $54 at Piper Sandler 01/06/21 Deutsche Bank Morgan Stanley price target raised to $68 from $53 at Deutsche Bank 01/04/21 Fly Intel: Top five analyst upgrades MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/20/21 Morgan Stanley reports Q4 EPS $1.81, consensus $1.27 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/05/21 Oatly planning 2021 initial public offering, CNBC reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/22/20 Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says 12/22/20 'James Bond' studio MGM Holdings exploring sale, WSJ reports MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/20/21 Fly Intel: Wall Street's top stories for Wednesday 01/20/21 Fly Intel: Wall Street's top stories at midday 01/20/21 Fly Intel: Pre-market Movers 11/10/20 Square, Wayfair upgrades among today's top calls on Wall Street 02/24/21 22nd Annual Virtual Financial Services Forum MS Morgan Stanley $74.83 / -0.16 (-0.21%) 01/15/21 Unusual call flow in option market yesterday 01/14/21 $1.3M call seller in Morgan Stanley opens two week position into earnings 01/12/21 Unusual call flow in option market yesterday 01/11/21 Diagonal call spread in Morgan Stanley rolls $16M premium position

Hot Stocks	Travelers reports book value per share of $115.68, up 14% from year-end 2019 » 06:58 01/21/21 01/21 06:58 01/21/21 06:58 TRV Travelers $145.04 / +1.5 (+1.05%) Reports adjusted book… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TRV Travelers $145.04 / +1.5 (+1.05%) 12/03/20 Travelers acquires InsuraMatch from Plymouth Rock Group, terms not disclosed 10/20/20 Travelers CEO says net written premiums in Q3 up nearly 3% 10/20/20 Travelers reports Q3 return on equity of 12.1%, core return on equity 13.5% 10/20/20 Travelers reports Q3 adj. book value per share $94.89 TRV Travelers $145.04 / +1.5 (+1.05%) 01/04/21 JPMorgan Travelers price target raised to $136 from $129 at JPMorgan 11/27/20 MKM Partners Travelers price target raised to $160 from $140 at MKM Partners 11/17/20 Barclays Travelers initiated with an Overweight at Barclays 10/29/20 BofA Chubb upgraded to Neutral at BofA with valuation gap to Travelers narrowed TRV Travelers $145.04 / +1.5 (+1.05%) 06:57 Today Travelers reports Q4 core EPS $4.91, consensus $3.18 10/20/20 Travelers reports Q3 core EPS $3.12, consensus $3.00 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) TRV Travelers $145.04 / +1.5 (+1.05%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open TRV Travelers $145.04 / +1.5 (+1.05%) 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Pre-market Movers 07/23/20 Fly Intel: Wall Street's top stories for Thursday 09:00 Today Travelers - TRV
Earnings	Travelers reports Q4 core EPS $4.91, consensus $3.18 » 06:57 01/21/21 01/21 06:57 01/21/21 06:57 TRV Travelers $145.04 / +1.5 (+1.05%) Reports Q4 revenue $8.4B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TRV Travelers $145.04 / +1.5 (+1.05%) 12/03/20 Travelers acquires InsuraMatch from Plymouth Rock Group, terms not disclosed 10/20/20 Travelers CEO says net written premiums in Q3 up nearly 3% 10/20/20 Travelers reports Q3 return on equity of 12.1%, core return on equity 13.5% 10/20/20 Travelers reports Q3 adj. book value per share $94.89 TRV Travelers $145.04 / +1.5 (+1.05%) 01/04/21 JPMorgan Travelers price target raised to $136 from $129 at JPMorgan 11/27/20 MKM Partners Travelers price target raised to $160 from $140 at MKM Partners 11/17/20 Barclays Travelers initiated with an Overweight at Barclays 10/29/20 BofA Chubb upgraded to Neutral at BofA with valuation gap to Travelers narrowed TRV Travelers $145.04 / +1.5 (+1.05%) 10/20/20 Travelers reports Q3 core EPS $3.12, consensus $3.00 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) 07/23/20 Travelers reports Q2 core EPS (20c), consensus (20c) TRV Travelers $145.04 / +1.5 (+1.05%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open TRV Travelers $145.04 / +1.5 (+1.05%) 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Pre-market Movers 07/23/20 Fly Intel: Wall Street's top stories for Thursday 09:00 Today Travelers - TRV
Upgrade	Fluor upgraded to Buy from Hold at Vertical Research » 06:57 01/21/21 01/21 06:57 01/21/21 06:57 FLR Fluor $20.62 / -0.355 (-1.69%) Vertical Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options FLR Fluor $20.62 / -0.355 (-1.69%) 01/11/21 Fluor awarded reimbursable services contract from UAMPS 01/11/21 Fluor announces new business segments, initiates plans to sell Stork 12/15/20 Fluor's Stork awarded 26-month maintenance contract extension by Sitech 12/10/20 Fluor says current with all financial filings and debt requirements FLR Fluor $20.62 / -0.355 (-1.69%) 01/19/21 Citi Fluor price target raised to $22 from $19 at Citi 12/11/20 DA Davidson Fluor price target raised to $15 from $12 at DA Davidson 04/27/20 Citi Fluor downgraded to Neutral from Buy at Citi 04/27/20 UBS Fluor downgraded to Neutral from Buy at UBS FLR Fluor $20.62 / -0.355 (-1.69%) 12/10/20 Fluor reports Q3 EPS 14c, consensus 27c 11/12/20 Fluor reports Q2 EPS (19c), consensus 20c 10/22/20 Fluor reports Q1 EPS ($1.22), consensus 26c 09/25/20 Fluor suspends all prior 2020 guidance, provides update FLR Fluor $20.62 / -0.355 (-1.69%) 11/12/20 Fly Intel: Pre-market Movers 09/25/20 Fly Intel: Wall Street's top stories for Friday 09/25/20 Fly Intel: Wall Street's top stories at midday 09/25/20 Fly Intel: Pre-market Movers 02/26/21 Fluor - FLR 01/28/21 Fluor Corporation FLR Fluor $20.62 / -0.355 (-1.69%) 01/12/21 Early notable gainers among liquid option names on January 12th 11/18/20 Early notable gainers among liquid option names on November 18th 11/02/20 Early notable gainers among liquid option names on November 2nd 10/07/20 Fluor call volume above normal and directionally bullish
Upgrade	Oppenheimer upgrades 'uniquely positioned' Freshpet to Outperform » 06:55 01/21/21 01/21 06:55 01/21/21 06:55 FRPT Freshpet $146.47 / +2.39 (+1.66%) , SBH Sally Beauty $14.39 / +0.585 (+4.24%) , UTZ Utz Brands $23.31 / +1.55 (+7.12%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events FRPT SBH UTZ FRPT Freshpet $146.47 / +2.39 (+1.66%) 09/24/20 Freshpet completes CFO transition with appointment of Heather Pomerantz 08/31/20 Freshpet CFO Kassar sells 10,000 common shares 08/14/20 Freshpet launches multi-year corporate governance plan 08/03/20 Freshpet appoints Thembi Machaba as SVP, human resources SBH Sally Beauty $14.39 / +0.585 (+4.24%) 11/19/20 Sally Beauty announces launch of Buy Online, Pick Up In-Store program 11/17/20 Sysco appoints Aaron Alt as CFO 11/17/20 Sally Beauty names Mary Beth Edwards as Chief Information Officer 11/17/20 Sally Beauty CFO Aaron Alt to leave company, Marlo Cormier to succeed UTZ Utz Brands $23.31 / +1.55 (+7.12%) 01/11/21 Utz Brands to acquire Vitner's brand assets for $25M, sees accretion 12/14/20 Utz Brands completes acquisition of On The Border 11/23/20 Utz Brands CEO: We're really excited about the Truco acquisition 11/12/20 Utz Brands expects Truco to generate about $195M in net sales in FY20 FRPT SBH UTZ FRPT Freshpet $146.47 / +2.39 (+1.66%) 05:25 Today Oppenheimer Freshpet upgraded to Outperform from Perform at Oppenheimer 01/19/21 Stephens Freshpet initiated with an Overweight at Stephens 01/19/21 JPMorgan Freshpet price target raised to $170 from $160 at JPMorgan 01/14/21 Truist Freshpet price target raised to $140 from $120 at Truist SBH Sally Beauty $14.39 / +0.585 (+4.24%) 01/20/21 Morgan Stanley Sally Beauty upgraded to Equal Weight from Underweight at Morgan Stanley 06/04/20 Oppenheimer Sally Beauty upgraded to Outperform at Oppenheimer 06/04/20 Oppenheimer Sally Beauty upgraded to Outperform from Perform at Oppenheimer 04/27/20 DA Davidson Sally Beauty price target lowered to $10 from $14.50 at DA Davidson UTZ Utz Brands $23.31 / +1.55 (+7.12%) 01/20/21 Citi Utz Brands price target raised to $26 from $21 at Citi 01/19/21 Stephens Utz Brands initiated with an Overweight at Stephens 12/22/20 Piper Sandler Utz Brands price target raised to $25 from $22 at Piper Sandler 12/21/20 Goldman Sachs Utz Brands reinstated with a Neutral at Goldman Sachs FRPT SBH UTZ FRPT Freshpet $146.47 / +2.39 (+1.66%) 01/13/21 Freshpet sees Q4 revenue $84.5M, consensus $88.41M 01/13/21 Freshpet sees Q4 net sales $84.5M, consensus $88.41M 01/13/21 Freshpet sees FY20 net sales $318.8M, consensus $322.73M 11/02/20 Freshpet backs FY20 revenue view $320M, consensus $321.89M SBH Sally Beauty $14.39 / +0.585 (+4.24%) 11/12/20 Sally Beauty not providing formal FY21 guidance at this time 11/12/20 Sally Beauty reports Q4 adjusted EPS 63c, consensus 56c 11/11/20 Notable companies reporting before tomorrow's open 11/11/20 Notable companies reporting before tomorrow's open UTZ Utz Brands $23.31 / +1.55 (+7.12%) 11/05/20 Utz Brands sees FY20 revenue growth 10%-11%, consensus $949.32M 11/05/20 Utz Brands reports Q3 revenue $248.0M, consensus $246.11M 27 Feb FRPT SBH UTZ FRPT Freshpet $146.47 / +2.39 (+1.66%) 11/02/20 Fly Intel: After-Hours Movers 08/03/20 Fly Intel: After-Hours Movers SBH Sally Beauty $14.39 / +0.585 (+4.24%) 11/12/20 Fly Intel: Pre-market Movers 09/30/20 Fly Intel: After-Hours Movers UTZ Utz Brands $23.31 / +1.55 (+7.12%) 11/13/20 Disney upgrade among today's top calls on Wall Street 09/21/20 Fly Intel: After-Hours Movers 01/28/21 Sally Beauty Holdings Inc.
Recommendations	Lithium Americas price target raised to C$20 from C$13 at BMO Capital » 06:55 01/21/21 01/21 06:55 01/21/21 06:55 LAC Lithium Americas $22.24 / -4.565 (-17.03%) BMO Capital analyst Joel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options LAC Lithium Americas $22.24 / -4.565 (-17.03%) 01/20/21 Lithium Americas falls -17.8% 01/20/21 Lithium Americas falls -13.9% 01/20/21 Lithium Americas falls -14.9% 01/20/21 Lithium Americas trading resumes LAC Lithium Americas $22.24 / -4.565 (-17.03%) 01/06/21 Canaccord Lithium Americas price target raised to C$20 from C$11.50 at Canaccord 12/23/20 Stifel Stifel starts Lithium Americas with Buy, sees 'attractive upside' 12/22/20 Stifel Lithium Americas initiated with a Buy at Stifel 10/21/20 Roth Capital Lithium Americas downgraded to Neutral from Buy at Roth Capital LAC Lithium Americas $22.24 / -4.565 (-17.03%) 08/14/20 Lithium Americas reports Q2 EPS (7c) vs. (7c) last year 20 Jan LAC Lithium Americas $22.24 / -4.565 (-17.03%) 01/19/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: After-Hours Movers 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day LAC Lithium Americas $22.24 / -4.565 (-17.03%) 01/13/21 Lithium Americas call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/22/20 Lithium Americas call volume above normal and directionally bullish 12/18/20 Largest borrow rate increases among liquid names

Upgrade	Occidental Petroleum upgraded to Hold from Underperform at Jefferies » 06:55 01/21/21 01/21 06:55 01/21/21 06:55 OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 12/21/20 Tesla set to join S&P 500 & S&P 100 at open on 12/21 12/15/20 Occidental subsidiary awarded tundra carbon storage consulting services contract 12/11/20 Tesla set to join S&P 500 & S&P 100 at open on 12/21 11/13/20 Icahn reduces stake in Herbalife, boosts stake in Xerox OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 01/19/21 Societe Generale Societe Generale starts Occidental at Hold after doubling of shares 01/19/21 Societe Generale Occidental Petroleum initiated with a Hold at Societe Generale 01/14/21 Barclays Occidental Petroleum price target raised to $23 from $18 at Barclays 01/11/21 Mizuho Occidental Petroleum upgraded to Buy from Neutral at Mizuho OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 11/09/20 Occidental Petroleum reports adjusted Q3 (84c), consensus (72c) 08/10/20 Occidental sees Q4 production of 1,300-1,330 Mboed 08/10/20 Occidental sees Q3 production of 1,200-1,250 Mboed 08/10/20 Occidental sees second half capital spend of 700M-$900M OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 07/29/20 Occidental in talks to sell $4.5B in assets to Pertamina, Bloomberg reports OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 12/21/20 Tesla under pressure on first trading day on S&P 500 Index 08/10/20 Fly Intel: After-Hours Movers 02/17/21 Occidental Petroleum - OXY OXY Occidental Petroleum $22.99 / -0.06 (-0.26%) 01/12/21 Early notable gainers among liquid option names on January 12th 01/05/21 Occidental Petroleum call volume above normal and directionally bullish 01/05/21 Early notable gainers among liquid option names on January 5th 12/23/20 Occidental Petroleum call volume above normal and directionally bullish
Initiation	Neste initiated with a Hold at Jefferies » 06:53 01/21/21 01/21 06:53 01/21/21 06:53 NTOIY Neste $0.00 / + (+0.00%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research NTOIY Neste $0.00 / + (+0.00%) 11/03/20 Bunge to sell Rotterdam facility to Neste for EUR 258M in cash NTOIY Neste $0.00 / + (+0.00%) 01/15/21 JPMorgan Neste price target raised to EUR 55 from EUR 52 at JPMorgan 01/08/21 Redburn Neste downgraded to Neutral from Buy at Redburn 12/02/20 JPMorgan Neste price target raised to EUR 52 from EUR 38 at JPMorgan 12/02/20 UBS Neste price target raised to EUR 54 from EUR 37 at UBS
Recommendations	FirstEnergy price target lowered to $29 from $30 at Mizuho » 06:53 01/21/21 01/21 06:53 01/21/21 06:53 FE FirstEnergy $31.33 / +0.22 (+0.71%) Mizuho analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FE FirstEnergy $31.33 / +0.22 (+0.71%) 01/19/21 FirstEnergy utilities issue RFP for solar energy credits 01/05/21 FirstEnergy appoints Hyun Park as Chief Legal Officer 11/17/20 FirstEnergy receives not in compliance letter from NYSE 10/29/20 FirstEnergy announces termination of CEO Charles Jones FE FirstEnergy $31.33 / +0.22 (+0.71%) 01/06/21 Wells Fargo Wells Fargo says buy CenterPoint Energy, sell FirstEnergy 01/06/21 Wells Fargo FirstEnergy downgraded to Underweight from Equal Weight at Wells Fargo 12/01/20 Wells Fargo FirstEnergy downgraded to Equal Weight amid investigations at Wells Fargo 12/01/20 Wells Fargo FirstEnergy downgraded to Equal Weight from Overweight at Wells Fargo FE FirstEnergy $31.33 / +0.22 (+0.71%) 11/02/20 FirstEnergy reports Q3 adj. EPS 84c, consensus 79c 07/23/20 FirstEnergy reiterates long-term growth rate projections 07/23/20 FirstEnergy backs FY20 EPS view $2.40-$2.60, consensus $2.48 07/23/20 FirstEnergy sees Q3 EPS 73c-83c, consensus 76c FE FirstEnergy $31.33 / +0.22 (+0.71%) 11/16/20 FBI raids home of PUCO Chairman Sam Randazzo, Cincinnati Enquirer reports 10/14/20 Federal prosecutors asked Energy Harbor for documents, WSJ reports 09/23/20 FirstEnergy sued by Ohio AG for 'pattern of corrupt activity,' Bloomberg says 07/21/20 Ohio House Speaker arrested in $60M bribery case, Cleveland.com reports FE FirstEnergy $31.33 / +0.22 (+0.71%) 10/30/20 Fly Intel: Wall Street's top stories at midday 07/23/20 Fly Intel: After-Hours Movers 07/22/20 IBM, Coca-Cola upgrades among today's top calls on Wall Street 07/22/20 Fly Intel: Pre-market Movers FE FirstEnergy $31.33 / +0.22 (+0.71%) 11/24/20 FirstEnergy put volume heavy and directionally bearish 11/20/20 FirstEnergy put volume heavy and directionally bearish 11/19/20 FirstEnergy put volume heavy and directionally bearish 11/10/20 FirstEnergy put volume heavy and directionally bearish
Recommendations	Citi adds Tandem, removes Guardant from 'Value Creators' list » 06:52 01/21/21 01/21 06:52 01/21/21 06:52 TNDM TNDM / + , GH Guardant Health $163.38 / +3.38 (+2.11%) Citi strategist Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events TNDM GH TNDM TNDM / + 11/23/20 Tandem Diabetes enters new agreements with DexCom 11/23/20 Tandem says Health Canada approves t:slim X2 Insulin pump GH Guardant Health $163.38 / +3.38 (+2.11%) 01/19/21 Guardant Health CEO sells 150K shares of common stock 01/18/21 Guardant Health announces partnership with Vall d'Hebron Institute of Oncology 01/11/21 Guardant Health to launch Guardant Reveal colon cancer liquid biopsy test 12/11/20 Guardant Health names Michael Bell as new CFO, succeeding Derek Bertocci TNDM GH TNDM TNDM / + 12/15/20 Wells Fargo Wells Fargo says Buy Inari Medical, Sell NuVasive in MedTech ratings shake-up 12/15/20 Wells Fargo Tandem Diabetes downgraded to Equal Weight from Overweight at Wells Fargo 11/06/20 Piper Sandler Tandem Diabetes price target raised to $132 from $125 at Piper Sandler 10/16/20 Citi Citi opens 'positive catalyst watch' on DexCom GH Guardant Health $163.38 / +3.38 (+2.11%) 01/14/21 Canaccord Natera price target raised to $125 from $112 at Canaccord 01/12/21 Canaccord Guardant Health price target raised to $170 from $145 at Canaccord 01/11/21 Fly Intel: Top five analyst initiations 01/11/21 Stifel Guardant Health initiated with a Buy at Stifel TNDM GH TNDM TNDM / + 11/05/20 Tandem Diabetes raises FY20 revenue view to $465M-$475M from $450M-$465M 11/05/20 Tandem Diabetes reports Q3 EPS (15c), consensus (10c) 07/30/20 Tandem Diabetes reinstates FY20 revenue view to $450M-$465M, consensus $417.2M 07/30/20 Tandem Diabetes reports Q2 EPS (45c), consensus (24c) GH Guardant Health $163.38 / +3.38 (+2.11%) 11/05/20 Guardant Health reports Q3 GAAP EPS (78c), consensus (38c) 08/06/20 Guardant Health reports Q2 EPS (57c), consensus (38c) 07 Oct 02 Jun TNDM GH TNDM TNDM / + 08/11/20 Medtronic rises following acquisition of insulin pen maker Companion 07/31/20 Fly Intel: Alphabet downgrade among today's top calls on Wall Street GH Guardant Health $163.38 / +3.38 (+2.11%) 10/06/20 Fly Intel: After-Hours Movers 02/24/21 Tandem Diabetes - TNDM
Earnings	BankUnited reports Q4 EPS 89c, consensus 70c » 06:51 01/21/21 01/21 06:51 01/21/21 06:51 BKU BankUnited $38.48 / -0.34 (-0.88%) Reports Q4 net recovery… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BKU BankUnited $38.48 / -0.34 (-0.88%) 09/01/20 BankUnited to replace Lithia Motors in S&P 600 at open on 9/1 08/25/20 S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices 08/25/20 BankUnited to replace Lithia Motors in S&P 600 at open on 9/1 08/14/20 BankUnited hires Kevin Malcolm as General Counsel BKU BankUnited $38.48 / -0.34 (-0.88%) 01/08/21 UBS BankUnited downgraded to Neutral from Buy at UBS 01/05/21 RBC Capital BankUnited price target raised to $39 from $29 at RBC Capital 12/17/20 Seaport Global Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys 12/17/20 Seaport Global BankUnited initiated with a Buy at Seaport Global BKU BankUnited $38.48 / -0.34 (-0.88%) 10/28/20 BankUnited reports Q3 EPS 70c, consensus 63c 07/29/20 BankUnited reports Q2 EPS 80c, consensus 22c BKU BankUnited $38.48 / -0.34 (-0.88%) 08/25/20 Fly Intel: After-Hours Movers 09:00 Today BankUnited - BKU

Initiation	Galp Energia initiated with a Hold at Jefferies » 06:51 01/21/21 01/21 06:51 01/21/21 06:51 GLPEY Galp Energia $0.00 / + (+0.00%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research GLPEY Galp Energia $0.00 / + (+0.00%) 01/15/21 JPMorgan Galp Energia price target lowered to EUR 11 from EUR 11.50 at JPMorgan 01/14/21 Credit Suisse Galp Energia price target lowered to EUR 13 from EUR 13.40 at Credit Suisse 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/14/21 Societe Generale Galp Energia downgraded to Hold from Buy at Societe Generale
Initiation	Repsol initiated with a Hold at Jefferies » 06:49 01/21/21 01/21 06:49 01/21/21 06:49 REPYY Repsol $0.00 / + (+0.00%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research REPYY Repsol $0.00 / + (+0.00%) 01/15/21 JPMorgan Repsol price target raised to EUR 8.50 from EUR 8 at JPMorgan 01/14/21 Credit Suisse Repsol price target raised to EUR 10 from EUR 9.50 at Credit Suisse 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/11/21 Morgan Stanley Repsol price target raised to EUR 8.55 from EUR 7.50 at Morgan Stanley
Recommendations	UBS sees 'golden' risk reward for McDonald's » 06:49 01/21/21 01/21 06:49 01/21/21 06:49 MCD McDonald's / + UBS analyst Dennis Geiger… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MCD McDonald's / + 12/07/20 Allete announces renewable energy agreement with McDonald's 12/07/20 Apex Clean Energy announces two PPA with McDonald's 11/19/20 Jack in the Box CEO says team working on new chicken program 11/09/20 Beyond Meat says worked very hard to develop McDonald's McPlant burger MCD McDonald's / + 01/19/21 Goldman Sachs McDonald's initiated with a Buy at Goldman Sachs 01/07/21 Fly Intel: Top five analyst upgrades 01/07/21 Oppenheimer Opco upgrades McDonald's to Outperform for first time since 2021 01/07/21 Oppenheimer McDonald's upgraded to Outperform from Perform at Oppenheimer MCD McDonald's / + 11/09/20 McDonald's reports Q3 ex-items EPS $2.22, consensus $1.90 07/28/20 McDonald's reports Q2 EPS 66c, consensus 74c 07/27/20 Notable companies reporting before tomorrow's open 07/27/20 Notable companies reporting before tomorrow's open MCD McDonald's / + 01/04/21 McDonald's to launch 3 new chicken sandwiches in U.S. in February, Reuters says 12/09/20 McDonald's franchisees plan to raise Happy Meal prices, WSJ reports 11/16/20 McDonald's to increase inspections to ward off 'Covid fatigue,' NYP reports 11/09/20 Beyond Meat up 4% after confirming partnership with McDonald's for 'McPlant' MCD McDonald's / + 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 01/06/21 Coca-Cola, PepsiCo downgrades among today's top calls on Wall Street 01/05/21 Tesla downgrade, McDonald's initiation among today's top calls on Wall Street 01/04/21 Airbnb, DoorDash coverage initiations among today's top calls on Wall Street 01/28/21 McDonald's - MCD 01/22/21 Mapping Your Corporate Social Responsibility MCD McDonald's / + 09/09/20 Unusually active option classes on open September 9th 09/02/20 McDonald's call volume above normal and directionally bullish 08/17/20 Unusually active option classes on open August 17th 07/28/20 Unusually active option classes on open July 28th
Upgrade	Ramsay Health Care upgraded to Buy from Neutral at Citi » 06:49 01/21/21 01/21 06:49 01/21/21 06:49 RMSYF Ramsay Health Care $0.00 / + (+0.00%) Citi analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research RMSYF Ramsay Health Care $0.00 / + (+0.00%) 01/15/21 Goldman Sachs Ramsay Health Care upgraded to Conviction Buy from Neutral at Goldman Sachs 04/23/20 Citi Ramsay Health Care downgraded to Neutral from Buy at Citi 03/27/20 Goldman Sachs Ramsay Health Care upgraded to Neutral from Sell at Goldman Sachs
Upgrade	CSL upgraded to Buy from Neutral at Citi » 06:48 01/21/21 01/21 06:48 01/21/21 06:48 CSLLY CSL $0.00 / + (+0.00%) Citi analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly CSLLY CSL $0.00 / + (+0.00%) 11/02/20 CSL granted Orphan Drug Designation for CSL889 from FDA, EC 08/24/20 Grifols jumps after FDA issues emergency use authorization for plasma CSLLY CSL $0.00 / + (+0.00%) 11/11/20 JPMorgan CSL upgraded to Overweight from Neutral at JPMorgan 08/20/20 Citi CSL downgraded to Neutral from Buy at Citi 05/28/20 Citi CSL upgraded to Buy from Neutral at Citi 04/14/20 Citi CSL downgraded to Neutral from Buy at Citi CSLLY CSL $0.00 / + (+0.00%) 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports CSLLY CSL $0.00 / + (+0.00%) 08/24/20 Fly Intel: Wall Street's top stories for Monday 08/24/20 Plasma producers spike after EUA issued for convalescent plasma to treat COVID

Initiation	OMV AG initiated with a Buy at Jefferies » 06:48 01/21/21 01/21 06:48 01/21/21 06:48 OMVKY OMV AG $0.00 / + (+0.00%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research OMVKY OMV AG $0.00 / + (+0.00%) 12/15/20 H2Accelerate participants collaborate for hydrogen trucking roll-out OMVKY OMV AG $0.00 / + (+0.00%) 01/15/21 JPMorgan OMV AG price target raised to EUR 44 from EUR 40 at JPMorgan 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/11/21 Morgan Stanley OMV AG price target raised to EUR 44 from EUR 36.70 at Morgan Stanley 12/09/20 Berenberg OMV AG price target raised to EUR 38 from EUR 34 at Berenberg
Upgrade	Cochlear upgraded to Neutral from Sell at Citi » 06:48 01/21/21 01/21 06:48 01/21/21 06:48 CHEOY Cochlear $0.00 / + (+0.00%) Citi analyst John… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CHEOY Cochlear $0.00 / + (+0.00%) 03/17/20 Citi Cochlear upgraded to Neutral from Sell at Citi 03/12/20 Jefferies Cochlear upgraded to Hold from Underperform at Jefferies 02/20/20 Goldman Sachs Cochlear downgraded to Sell from Neutral at Goldman Sachs 02/18/20 Morgan Stanley ResMed downgraded to Equal Weight on valuation at Morgan Stanley
Initiation	Eni SpA initiated with a Hold at Jefferies » 06:46 01/21/21 01/21 06:46 01/21/21 06:46 E Eni SpA $21.68 / +0.2 (+0.93%) Jefferies analyst Giacomo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research E Eni SpA $21.68 / +0.2 (+0.93%) 01/15/21 JPMorgan Eni SpA price target raised to EUR 9 from EUR 8.50 at JPMorgan 01/14/21 Societe Generale Societe Generale downgrades three EU oil & gas names after strong performances 01/13/21 Credit Suisse Eni SpA price target raised to EUR 10 from EUR 9.20 at Credit Suisse 01/11/21 Morgan Stanley Eni SpA price target raised to EUR 8.20 from EUR 6 at Morgan Stanley
Recommendations	Callon Petroleum price target raised to $16 from $6 at Citi » 06:46 01/21/21 01/21 06:46 01/21/21 06:46 CPE Callon Petroleum $14.86 / -0.82 (-5.23%) Citi analyst Brian Downey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CPE Callon Petroleum $14.86 / -0.82 (-5.23%) 12/04/20 Callon Petroleum rises 26.0% 12/04/20 Callon Petroleum rises 12.0% 11/03/20 Callon Petroleum sees FY20 production 100-101 Mboe/d 10/01/20 Callon announces $170M in asset monetizations, $300M from notes issuance CPE Callon Petroleum $14.86 / -0.82 (-5.23%) 12/31/20 Truist Callon Petroleum price target raised to $14 from $6 at Truist 12/17/20 RBC Capital Callon Petroleum price target raised to $20 from $16 at RBC Capital 11/04/20 MKM Partners Callon Petroleum price target raised to $15 from $10 at MKM Partners 11/04/20 Northland Callon Petroleum price target lowered to $7 from $10 at Northland CPE Callon Petroleum $14.86 / -0.82 (-5.23%) 11/03/20 Callon Petroleum reports Q3 adj. EPS 64c, consensus 0c 08/04/20 Callon Petroleum reports Q2 adj. EPS 1c, consensus (5c) CPE Callon Petroleum $14.86 / -0.82 (-5.23%) 10/01/20 Fly Intel: Pre-market Movers 09/25/20 Cruise Line upgrades among today's top calls on Wall Street 02/25/21 Callon Petroleum - CPE CPE Callon Petroleum $14.86 / -0.82 (-5.23%) 11/25/20 Largest borrow rate increases among liquid names 11/06/20 Largest borrow rate increases among liquid names
Hot Stocks	Store Capital announces January rent collections of 91% » 06:46 01/21/21 01/21 06:46 01/21/21 06:46 STOR Store Capital $31.36 / +0.62 (+2.02%) As of January 20, Store… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings STOR Store Capital $31.36 / +0.62 (+2.02%) 01/11/21 Store Capital announces acquisition activity for 2020 12/22/20 Store Capital announces December rent collections of 90% 11/23/20 Store Capital announces November rent collections of 90% 10/21/20 Store Capital announces October rent collections of 90% STOR Store Capital $31.36 / +0.62 (+2.02%) 12/16/20 Baird Store Capital downgraded to Neutral from Outperform at Baird 12/11/20 Truist Store Capital price target raised to $30 from $27 at Truist 12/10/20 Wells Fargo Store Capital upgraded to Overweight from Equal Weight at Wells Fargo 12/10/20 Wells Fargo Store Capital upgraded to Overweight from Equal Weight at Wells Fargo STOR Store Capital $31.36 / +0.62 (+2.02%) 08/05/20 Store Capital reports Q2 adjusted FFO 44c, consensus 44c

Events

Earnings calls, analyst events, roadshows and more

SI
Today at 08:00

Silvergate Capital - SI Conference Calls
BEDU
Today at 08:00

Bright Scholar - BEDU Conference Calls
DFS
Today at 08:00

Discover - DFS Conference Calls
WNS
Today at 08:00

WNS Holdings - WNS Conference Calls
TAL
Today at 08:00

TAL Education - TAL Conference Calls
STL
Today at 08:00

Sterling Bancorp - STL Conference Calls
TFC
Today at 08:00

Truist Financial - TFC Conference Calls
CTXS
Today at 08:15

Citrix - CTXS Conference Calls
PLXS
Today at 08:30

Plexus - PLXS Conference Calls
UNP
Today at 08:45

Union Pacific - UNP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG $5.76 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Mack-Cali Realty announces $61M sale of NJ property

TODAY'S FREE FLY STORIES

Get Full Fly Access